| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Fraki JE et al. | Correlation of epidermal plasminogen activator activity with disease activity in psoriasis. | 1983 | Br. J. Dermatol. | pmid:6336944 |
| Fontan B et al. | Toxic effects of the aromatic retinoid etretinate. | 1983 | Arch Dermatol | pmid:6824354 |
| Amato S et al. | [Impetigo herpetiformis and aromatic retinoid]. | 1983 Jul-Aug | G Ital Dermatol Venereol | pmid:6671698 |
| Bertani E et al. | [Lewandowsky-Lutz epidermodysplasia verruciformis. Considerations on 2 cases in adults]. | 1983 Sep-Oct | G Ital Dermatol Venereol | pmid:6321331 |
| Marghescu S et al. | [Congenital reticular ichthyosiform erythroderma]. | 1984 | Hautarzt | pmid:6500934 |
| Vanderveen EE and Ellis CN | Methotrexate and etretinate in the treatment of psoriasis. | 1984 | Arch Dermatol | pmid:6508327 |
| Bruynzeel-Koomen CA and de Wit RF | Confluent and reticulated papillomatosis successfully treated with the aromatic etretinate. | 1984 | Arch Dermatol | pmid:6476862 |
| Happle R et al. | [Teratogenic effects of etretinate in humans]. | 1984 | Dtsch. Med. Wochenschr. | pmid:6479047 |
| Yemane-Berhan T | Oral treatment of psoriasis with etretinate. | 1984 | Ethiop. Med. J. | pmid:6479157 |
| Beer WE and Smith NP | Hyperkeratotic porokeratosis (Mibelli) with psoriasis--response to an aromatic retinoid. | 1984 | Clin. Exp. Dermatol. | pmid:6488582 |
| Baran R | Etretinate therapy. | 1984 | Arch Dermatol | pmid:6465922 |
| Wolff K and Hönigsmann H | Retinoids and PUVA in psoriasis. | 1984 | Br. J. Dermatol. | pmid:6466564 |
| Hodak E et al. | Excess granulation tissue during etretinate therapy. | 1984 | J. Am. Acad. Dermatol. | pmid:6512060 |
| Kawamura K | [The effects of retinoid on normal and acanthotic epidermis--cytofluorometric study]. | 1984 | Nihon Hifuka Gakkai Zasshi | pmid:6513094 |
| Lahmar L et al. | [Generalized ichthyosis associated with a spastic syndrome of the lower limbs, a variant of Sjögren-Larsson syndrome? Light and electron microscopy study of ichthyosis and its evolution with oral etretinate treatment]. | 1984 | Ann Dermatol Venereol | pmid:6524807 |
| Thivolet J et al. | [Cowden's disease: efficacy of etretinate on cutaneous and digestive manifestations]. | 1984 | Ann Dermatol Venereol | pmid:6524814 |
| Mahrle G | [Retinoids and carcinogenesis]. | 1984 | Z. Hautkr. | pmid:6528691 |
| Camenzind M et al. | [Confetti ichthyosis]. | 1984 | Ann Dermatol Venereol | pmid:6529087 |
| Wargon O and Downie D | A case of mycosis fungoides treated with etretinate. | 1984 | Australas. J. Dermatol. | pmid:6529402 |
| Kanerva L et al. | Ichthyosis hystrix (Curth-Macklin). Light and electron microscopic studies performed before and after etretinate treatment. | 1984 | Arch Dermatol | pmid:6206802 |
| Benoldi D et al. | Reiter's disease: successful treatment of the skin manifestations with oral etretinate. | 1984 | Acta Derm. Venereol. | pmid:6209899 |
| Ferguson MM et al. | The treatment of erosive lichen planus with a retinoid--etretinate. | 1984 | Oral Surg. Oral Med. Oral Pathol. | pmid:6592525 |
| Cashin CH and Lewis EJ | Evaluation of hypervitaminosis A in the rat by measurement of tibial bone breaking strain. | 1984 | J Pharmacol Methods | pmid:6585601 |
| King IA | Increased epidermal hyaluronic acid synthesis caused by four retinoids. | 1984 | Br. J. Dermatol. | pmid:6586200 |
| Orfanos CE | Retinoids and psoriasis. | 1984 | Acta Derm Venereol Suppl (Stockh) | pmid:6596824 |
| Robinson JK et al. | Effect of retinoic acid and low calcium conditions on surface glycoconjugates defined by differential lectin labelling in mouse epidermal cell culture. | 1984 | Br. J. Dermatol. | pmid:6362708 |
| Ranki A et al. | Effect of etretinate on the distribution of Langerhans cells and T. lymphocytes in psoriatic skin. | 1984 | Arch. Dermatol. Res. | pmid:6609684 |
| Schnitzler L | [Xeroderma pigmentosum]. | 1984 | Ann Dermatol Venereol | pmid:6732120 |
| Benoldi D and Alinovi A | Multiple persistent keratoacanthomas: treatment with oral etretinate. | 1984 | J. Am. Acad. Dermatol. | pmid:6736321 |
| English JS and Roberts DT | Treatment of hyperkeratotic conditions of the legs with etretinate. | 1984 | J. Am. Acad. Dermatol. | pmid:6736328 |
| Thianprasit M | Chronic cutaneous arsenism treated with aromatic retinoid. | 1984 | J Med Assoc Thai | pmid:6736831 |
| Christiansen JV et al. | Patients' acceptance of etretinate therapy. A retrospective survey of long-term etretinate therapy in chronic keratotic and pustular skin diseases. | 1984 | Dermatologica | pmid:6714503 |
| Pichler E and Fritsch P | [Xeroderma pigmentosum: prevention of tumors with etretinate]. | 1984 | Hautarzt | pmid:6715172 |
| Brenner S and Yust I | Treatment of scleromyxedema with etretinate. | 1984 | J. Am. Acad. Dermatol. | pmid:6715602 |
| Glazer SD et al. | Ultrastructural survey and tissue analysis of human livers after a 6-month course of etretinate. | 1984 | J. Am. Acad. Dermatol. | pmid:6715613 |
| Chung JC et al. | Diazacholesterol-induced ichthyosis in the hairless mouse. Assay for comparative potency of topical retinoids. | 1984 | Arch Dermatol | pmid:6703735 |
| Oguchi H | [Application of the aromatic retinoid etretinate in oral cancer therapy. Experimental study of the use of the aromatic retinoid etretinate alone and in combination with peplomycin in oral cancer therapy]. | 1984 | Tsurumi Shigaku | pmid:6204429 |
| Hatchell DL et al. | Treatment of xerophthalmia with retinol, tretinoin, and etretinate. | 1984 | Arch. Ophthalmol. | pmid:6732578 |
| Dicken CH | Retinoids: a review. | 1984 | J. Am. Acad. Dermatol. | pmid:6208221 |
| Studer UE et al. | Prevention of recurrent superficial bladder tumors by oral etretinate: preliminary results of a randomized, double blind multicenter trial in Switzerland. | 1984 | J. Urol. | pmid:6361284 |
| Fujita J and Yoshida O | [Inhibitory effects of aromatic retinoic acid analog, administered alone or in combination with mitomycin C, on the in vitro growth of rat bladder carcinoma cells]. | 1984 | Hinyokika Kiyo | pmid:6241424 |
| Parker S et al. | A randomized double-blind comparison of PUVA-etretinate and PUVA-placebo in the treatment of chronic plaque psoriasis. | 1984 | Br. J. Dermatol. | pmid:6365147 |
| Presbury DG | Intractable skin disorders treated with the aromatic retinoid etretinate. | 1984 | S. Afr. Med. J. | pmid:6369566 |
| Horber FF et al. | Impaired renal function and hypercalcaemia associated with etretinate. | 1984 | Lancet | pmid:6150159 |
| Alsina M et al. | [Therapeutic response of angiolymphoid hyperplasia to treatment with aromatic retinoic acid]. | 1984 | Med Cutan Ibero Lat Am | pmid:6397674 |
| Bordier C et al. | [Rupture of atrophic striae during pustular psoriasis treated with etretinate (Tigason)]. | 1984 | Ann Dermatol Venereol | pmid:6098213 |
| Armitstead JG and Ewan PW | Concanavalin A-induced suppressor cells. | 1984 | J Clin Lab Immunol | pmid:6201614 |
| Neuhofer J and Fritsch P | Treatment of localized scleroderma and lichen sclerosus with etretinate. | 1984 | Acta Derm. Venereol. | pmid:6203311 |
| Gerber LH et al. | Vertebral abnormalities associated with synthetic retinoid use. | 1984 | J. Am. Acad. Dermatol. | pmid:6586753 |
| Hein R et al. | Effect of vitamin A and its derivatives on collagen production and chemotactic response of fibroblasts. | 1984 | Br. J. Dermatol. | pmid:6234916 |
Etretinate
Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.
Cross Reference
Introduction
To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Etretinate?
Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Etretinate
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Etretinate?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Etretinate?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Etretinate?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Etretinate?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Etretinate?
There are no associated biomedical information in the current reference collection.